Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether BMS-936557 is effective for the treatment
of moderate to severely active Crohn's Disease in patients who have had insufficient response
and/or intolerance to conventional therapy for Crohn's Disease.